Indefinite Delivery Contract 75F40120D00012

Award Date 5/22/20
Last Date to Order 5/21/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Inventory
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Health and Human Services' Food and Drug Administration (FDA) awarded an Indefinite Delivery Contract (IDC) valued at $45 million to Iqvia Government Solutions Inc., a leading provider of healthcare data, analytics, and related services to federal agencies. The contract enables the FDA to issue task orders for access to outpatient prescription and patient-level drug utilization data to support its regulatory programs and post-market drug safety monitoring initiatives over a...
The Department of Health and Human Services Food and Drug Administration awarded a single award indefinite delivery contract to Iqvia Government Solutions Inc. to provide hospital drug utilization data and regulatory drug utilization services. The base period of performance is from March 2020 through March 2025 with a potential value of $9 million. Under the first delivery order valued at $3.667 million, Iqvia will deliver hospital drug data from Silver Spring, Maryland through April 2025. The...
The provided information describes a Indefinite Delivery Contract (IDC) awarded by the U.S. Food and Drug Administration (FDA), a civilian federal agency, to the prime contractor Syneos Health Research & Insights LLC. The IDC has a ceiling value of $3,446,837.42 and a period of performance from May 16, 2023 to May 16, 2025. The purpose of the contract is to provide the FDA with "ACCESS TO HEALTHCARE PRACTITIONER PRESCRIBING PRACTICES DATA". This requirement was originally solicited...
This indefinite delivery contract was awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to Iqvia Government Solutions Inc., a prominent healthcare data and analytics provider. The contract, valued at up to $3,169,963.15, provides the FDA with access to over-the-counter (OTC) drug utilization data to strengthen the agency's drug monitoring and safety surveillance programs. Through a series of firm fixed price delivery...
The Department of Health and Human Services Food and Drug Administration awarded a Blanket Purchase Agreement to Executive Information Systems LLC with a potential value of $49.9 million. Under this IDV and associated task orders, EIS will provide data analytics software, licenses, maintenance, customization, implementation, and ongoing support services. Key products and services delivered include SAS Foundation, JMP, and EDISH software and platforms. Task orders specify ongoing support for...
This Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to Iqvia Government Solutions Inc., a for-profit provider of advanced analytics, technology solutions, and clinical research services. The contract, valued at up to $2,397,717.80, is for ACCESS TO HOSPITAL INPATIENT AND EMERGENCY DEPARTMENT DRUG UTILIZATION DATA. This single-award IDC, which does not include any set-asides,...
The Department of Health and Human Services Food and Drug Administration awarded Deloitte Consulting LLP a blanket purchase agreement with a potential value of $90 million to provide scientific services under ordering agreement EO14042. Deloitte received multiple task orders against this vehicle from 2022 through 2026 to support various FDA programs. Services include regulatory analytics and assessment, data management, knowledge management capabilities development, workflow harmonization and...
The Department of Health and Human Services Food and Drug Administration awarded an Indefinite Delivery Contract with a potential value of $25 million to Midnight Sun Technologies LLC. The contract is a single award, 8(a) sole source set aside for scientific support services to be performed across multiple locations including Silver Spring, MD, Vienna, VA, and Calverton, MD. The contract aims to procure subject matter expertise through various labor categories such as Scientist III, Researcher...
The Department of Health and Human Services Food and Drug Administration awarded a single award Blanket Purchase Agreement to Contact Government Services LLC valued at up to $60,000,000 to provide eDiscovery operational support services and technology management. Under the terms of the BPA, the FDA issued an initial task order worth $5,779,831.34 for eDiscovery services with a period of performance from September 2023 through March 2026 in Washington D.C. The BPA and first task order aim to...
The Department of Health and Human Services Food and Drug Administration awarded an indefinite delivery contract to the National Academy of Sciences with a potential value of $30,000,000.00. The contract establishes a forum for the agency to convene committees for assessment, evaluations, and studies related to public health issues. Five task orders have been awarded against the contract to date, with periods of performance ranging from September 2022 through September 2025. Task orders...
  • 75F40120D00012
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

The Department of Health and Human Services Food and Drug Administration awarded a single-award Indefinite Delivery Contract to Source Healthcare Analytics LLC with a potential value of $45 million. Under the contract, Source Healthcare will provide the FDA access to outpatient prescription and patient level drug utilization data over a five-year period ending in May 2025.

Task Order 1 was issued with a firm fixed price value of $20.2 million. Source Healthcare will support the FDA's efforts to monitor drug safety and effectiveness through real-world data analysis by providing outpatient prescription and patient level drug utilization data. Performance will take place in Penllyn, Pennsylvania. No set-aside designations or subcontractors were identified.

The original solicitation sought access to outpatient prescription and patient level drug utilization data to aid the FDA's monitoring of drug safety and effectiveness using real-world data analysis. This contract and associated task orders aim to procure this real-world data to support the FDA in fulfilling its mission to protect public health through scientific and regulatory oversight of prescription drugs.

Generated 1/23/24, 3:06 PM